In our DLB group, higher Factors 2 and 3 and lower Factors 4 and 6, associated with lower disease severity on all other clinical measures, were associated with increasing t-Tau, p-Tau and p-Tau/AB42 ratio. The gene discussed is MAPT; the disease is Lewy body dementia.